A carregar...
Sodium-Glucose Cotransporter 2 Inhibitors Potentially Prevent Atrial Fibrillation by Ameliorating Ion Handling and Mitochondrial Dysfunction
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a novel class of glucose-lowering agents that significantly improve the prognosis of patients with type 2 diabetes (T2D) and heart failure. SGLT2i has recently been implicated in the treatment of atrial fibrillation (AF) with clinical data demon...
Na minha lista:
| Publicado no: | Front Physiol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7417344/ https://ncbi.nlm.nih.gov/pubmed/32848857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2020.00912 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|